Altria (NYSE: MO) stock couldn't quite make it over the hump of Hump Day. Investors traded out of tobacco titles generally on ...
Cigarette volumes in the U.S. keep sliding, yet nicotine pouches are exploding as the fastest-growing segment in oral tobacco ...
CB-011, an allogeneic CAR T product, received RMAT designation as treatment for multiple myeloma based on strong dose ...
SurvivorNet on MSN
FDA approves Eli Lilly’s daily GLP-1 weight loss pill under new fast-track program, expanding access and flexibility for patients
The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron, and ...
College of Nursing has announced updates to its Bachelor of Science in Nursing (BSN) pathway aimed at preparing students more ...
Popular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track Food and Drug ...
Greece has decided to extend its fast-track visa scheme for Turkish travelers visiting select Aegean islands for the second ...
Brittany Mahomes earned induction into the University of Texas at Tyler Athletics Hall of Fame after scoring a program record ...
Senate Bill 6026 prohibits Washington cities from requiring ground-floor retail for new housing. The package includes more ...
Graves-Blanks ran the early NCAA lead in the 110-meter hurdles, Liisa-Maria Lusti cracked Oregon’s all-time top 10, and the ...
A former software engineer in Oklahoma transitioned to welding after a tech industry layoff, finding stability and job ...
The FDA has granted Fast Track designation to BW-20805, an investigational small interfering RNA therapy for hereditary angioedema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results